Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan
Recruiting
Observational Study
Hepatitis C, Chronic
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 150,000 (estimated)
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
To determine the treatment efficacy, safety and long-term outcomes of chronic hepatitis C patients receiving directly acting antivirals in Taiwan
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1\. Patients who are treated with DAA and have willingness to participate in this registry.
Exclusion Criteria:
Chronic hepatitis C patients who are unwilling to participate in the study and do not provide written informed consent for participation.
Contacts